Trichosporon Asahii Superinfection in a Patient with COVID-19
Abstract
The use of immunosuppressant drugs to treat immunological storms in patients with severe coronavirus disease-2019 (COVID-19) infection has
increased considerations concerning fungal infections. In this patient subset with immune compromise, Trichosporon Asahii (T. asahii) may cause
significant mortality. In this case report, a 60-year-old patient who developed T. Asahii fungemia while being followed in the intensive care unit
due to COVID-19 pneumonia was presented.
Keywords
COVID-19, Trichosporon Asahii, Superinfection
Ethical Statement
Consent form was filled out by all participants.
References
- 1. Arastehfar A, Carvalho A, Nguyen MH, et al. COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? J Fungi (Basel). 2020;6:211.
- 2. Liao Y, Lu X, Yang S, Luo Y, Chen Q, Yang R, editors. Epidemiology and outcome of Trichosporon fungemia: a review of 185 reported cases from 1975 to 2014. Open forum infectious diseases; 2015: Oxford University Press.
- 3. Li H, Guo M, Wang C, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect. 2020;148:e169.
- 4. Nobrega de Almeida J Jr, Moreno L, Francisco EC, et al. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. Mycoses. 2021;64:817-822.
- 5. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.
- 6. Song G, Liang G, Liu W. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia. 2020;185:599-606.
- 7. Sterne JAC, Murthy S, Diaz JV, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta analysis. JAMA. 2020;324:1330-1341.
- 8. Segrelles-Calvo G, Glauber RDS, Llopis-Pastor E, et al. Trichosporon asahii as cause of nosocomial pneumonia in patient with COVID-19: a triple Coinfection. Arch Bronconeumol. 2021;57:46. 9. Ali GA, Husain A, Salah H, et al. Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature. IDCases. 2021;25:e01244.